Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Emerging Treatment Options in Mild to Moderate Ulcerative Colitis.
Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases.
The Genetic/Non-genetic Duality of Drug 'Resistance' in Cancer.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Emerging Treatment Options in Mild to Moderate Ulcerative Colitis.
Emerging Treatment Options in Mild to Moderate Ulcerative Colitis. Gastroenterol Hepatol (N Y). 2015 Mar; 11(3 Suppl 1):1-16.
View in:
PubMed
authors with profiles
Stephen B. Hanauer